Documents
-
Annual Report
10-K
Exhibits
-
3.4 Certificate of Designation of Series E Convertible Preferred Stock of 20/20 Biolabs, Inc
EX-3.4
-
4.1 Description of Securities of 20/20 Biolabs, Inc
EX-4.1
-
4.2 Warrant to Purchase Shares of Common Stock Issued by 20/20 Biolabs, Inc. to Streeterville Capital, LLC on February 19, 2026
EX-4.2
-
4.3 Warrant to Purchase Shares of Common Stock Issued by 20/20 Biolabs, Inc. to Maxim Partners LLC on February 19, 2026
EX-4.3
-
4.4 Warrant to Purchase Shares of Common Stock Issued by 20/20 Biolabs, Inc. to Streeterville Capital, LLC on February 9, 2026
EX-4.4
-
4.5 Warrant to Purchase Shares of Common Stock Issued by 20/20 Biolabs, Inc. to Maxim Partners LLC on February 9, 2026
EX-4.5
-
4.7 Warrant to Purchase Shares of Common Stock Issued by 20/20 Biolabs, Inc. to Maxim Partners LLC on November 17, 2025
EX-4.7
-
10.2 Secured Convertible Promissory Note Issued by 20/20 Biolabs, Inc. to Streeterville Capital, LLC on February 9, 2026
EX-10.2
-
14.1 Code of Business Conduct and Ethics
EX-14.1
-
19.1 Insider Trading Policy
EX-19.1
-
97.1 Clawback Policy
EX-97.1
Certifications, consents and other formalities 4
Certification
-
31.1 Certification
EX-31.1
-
31.2 Certification
EX-31.2
-
32.1 Certification
EX-32.1
-
32.2 Certification
EX-32.2
Data files 5
Financial data and other files for software
-
101.SCH XBRL Schema File
EX-101.SCH
-
101.CAL XBRL Calculation File
EX-101.CAL
-
101.DEF XBRL Definition File
EX-101.DEF
-
101.LAB XBRL Label File
EX-101.LAB
-
101.PRE XBRL Presentation File
EX-101.PRE
On sec.gov